Invention Grant
- Patent Title: GSK-3 inhibitors
-
Application No.: US15033813Application Date: 2014-11-03
-
Publication No.: US09718804B2Publication Date: 2017-08-01
- Inventor: Guanglin Luo , Ling Chen , Gene M. Dubowchik , Swanee E. Jacutin-Porte , Vivekananda M. Vrudhula , Senliang Pan , Prasanna Sivaprakasam , John E. Macor
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent James Epperson
- International Application: PCT/US2014/063691 WO 20141103
- International Announcement: WO2015/069594 WO 20150514
- Main IPC: C07D213/02
- IPC: C07D213/02 ; C07D401/14 ; C07D405/14 ; C07D413/14 ; C07D417/14 ; C07D487/04 ; C07D471/04
Abstract:
The disclosure generally relates to compounds of formula I, including their salts, as well as compositions and methods of using the compounds to treat disorders associated with GSK-3.
Public/Granted literature
- US20160272621A1 GSK-3 INHIBITORS Public/Granted day:2016-09-22
Information query
